Influence of leptin and the TNF system on insulin resistance in pregnancy and their effect on anthropometric parameters of newborns

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 5, 2003, Pages 432-438

  Melczer, Zsolt ^a   Bánhidy, Ferenc ^a   Csömör Jr , Sándor ^a   Tóth, Péter ^a   Kovács, Margit ^a   Winkler, Gábor ^c   Cseh, Károly ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Karolyi Hospital   (Hungary)

^c ST JOHN'S HOSPITAL   (Hungary)

Author keywords

Insulin resistance; Leptin; Newborn; Pregnancy; TNF

Indexed keywords

C PEPTIDE; INSULIN; LEPTIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ANTHROPOMETRY; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DEVELOPMENT; CONTROLLED STUDY; FEMALE; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; HEAD CIRCUMFERENCE; HUMAN; INSULIN RESISTANCE; NEWBORN; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADULT; ANTHROPOMETRY; ANTIGENS, CD; BIRTH WEIGHT; BODY HEIGHT; BODY MASS INDEX; C-PEPTIDE; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; INSULIN RESISTANCE; LEPTIN; PREGNANCY; PREGNANCY TRIMESTERS; RADIOIMMUNOASSAY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037563163     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.00127.x     Document Type: Article

References (20)

1. Zoupas C. Gestational diabetes mellitus. Diab Rev Internat 4 : 1995; 4-5: 5-7.
2. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EAH. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol 1991; 165: 1667-72.
3. Buchanan TA, Metzger BE, Freinkel N, Berman RN. Insulin sensitivity and beta-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990; 162: 1008-14.
4. Fernandez-Real JM, Broch M, Ricart W et al. Plasma levels of soluble fraction of tumor necrosis factor receptor-2 and insulin resistance. Diabetes 1998; 47: 1757-62.
5. Frühbeck G, Salvador J. Relation between leptin and the regulation of glucose metabolism. Diabetologia, 2000; 43: 3-12.
6. Arntzen KJ, Lien E, Austgulen R. Maternal serum levels of interleukin-6 and clinical characteristics of normal delivery at term. Acta Obstet Gynecol Scand 1997; 76: 55-60.
7. Sattar N, Greer IA, Pirwani I, Gibson J, Wallace AM. Leptin levels in pregnancy, marker for fat accumulation and mobilization? Acta Obstet Gynecol Scand 1998; 77: 278-83.
8. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha - a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-8.
9. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. J Clin Invest 1995; 95: 2111-9.
10. Liu LS, Spelleken M, Röhrig K, Hauner H, Eckel J. Tumor necrosis factor-alpha acutely inhibits insulin signalling in human adipocytes. Implication of the p80 tumor necrosis factor receptor. Diabetes 1998; 47: 515-22.
11. Ducy P, Amling M, Takeda S et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000; 100: 197-207.
12. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclasts differentiation and function by the new members of the tumor necrosis factor and ligand families. Endocr Rev 1999; 20: 345-57.
13. WHO/NCD/NCS. Report of a WHO Consultation. Definition diagnosis and classification of diabetes mellitus and its complications. Geneva: World Health Organization, 1999: 992.
14. Hotamisligil GS. Mechanisms of TNF-α induced insulin resistance. Exp Clin Endocrinol Diab 1999; 107: 119-25.
15. Fernandez-Real J-M, Broch M, Ricart W et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998; 47: 1757-62.
16. Rönnemaa T, Pulkki K, Kaprio J. Serum soluble tumor necrosis factor-α receptor 2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity. J Clin Endocrinol Metab 2000; 85: 2728-32.
17. Cseh K, Winkler G, Melczer Zs, Baranyi É. The role of tumour necrosis factor (TNF) -α resistance in obesity and insulin resistance. Diabetologia 2000; 43: 525.
18. Beckmann I, Visser W, Struijk PC, van Dooren M, Glavimans J, Wallenburg HCS. Circulating bioactive tumor necrosis factor-α, tumor necrosis factor-α receptors, fibronectin and tumor necrosis factor-α inducible cell adhesion molecule VCAM-1 in uncomplicated pregnancy. Am J Obstet Gynecol 1997; 177: 1247-52.
19. Breschi MC, Seghieri G, Bartolomei G. Relation of birth weight to maternal plasma glucose and insulin concentration during normal pregnancy. Diabetologia 1993; 36: 1315-21.
20. Grosfeld A, Turban S, Andre J et al. Transcriptional effect of hypoxia on placental leptin. FEBS Lett 2001; 502: 122-6.